Search Results - "Bel Imam, Manal"

Outcomes reported in randomized controlled trials for mixed and non‐IgE‐mediated food allergy: Systematic review by Bel Imam, Manal, Stikas, Charalampos‐Vlasios, Guha, Payal, Chawes, Bo L., Chu, Derek, Greenhawt, Matthew, Khaleva, Ekaterina, Munblit, Daniel, Nekliudov, Nikita, Veen, Willem, Schoos, Ann‐Marie M.

“…Background Mixed and non‐IgE‐mediated food allergy is a subset of immune‐mediated adverse food reactions that can impose a major burden on the quality of life…”
Get full text

B cells: The many facets of B cells in allergic diseases by Satitsuksanoa, Pattraporn, Iwasaki, Sayuri, Boersma, Jolien, Bel Imam, Manal, Schneider, Stephan R., Chang, Iris, van de Veen, Willem, Akdis, Mübeccel

“…B cells play a key role in our immune system through their ability to produce antibodies, suppress a proinflammatory state, and contribute to central immune…”
Get full text

Advances and highlights in biomarkers of allergic diseases by Ogulur, Ismail, Pat, Yagiz, Ardicli, Ozge, Barletta, Elena, Cevhertas, Lacin, Fernandez‐Santamaria, Ruben, Huang, Mengting, Bel Imam, Manal, Koch, Jana, Ma, Siyuan, Maurer, Debbie J., Mitamura, Yasutaka, Peng, Yaqi, Radzikowska, Urszula, Rinaldi, Arturo O., Rodriguez‐Coira, Juan, Satitsuksanoa, Pattraporn, Schneider, Stephan R., Wallimann, Alexandra, Zhakparov, Damir, Ziadlou, Reihane, Brüggen, Marie‐Charlotte, Veen, Willem, Sokolowska, Milena, Baerenfaller, Katja, Zhang, Luo, Akdis, Mubeccel, Akdis, Cezmi A.

“…During the past years, there has been a global outbreak of allergic diseases, presenting a considerable medical and socioeconomical burden. A large fraction of…”
Get full text

Mechanisms and biomarkers of successful allergen-specific immunotherapy by López, Juan-Felipe, Bel Imam, Manal, Satitsuksanoa, Pattraporn, Lems, Sophieke, Yang, Minglin, Hwang, Yu-Kyoung, Losol, Purevsuren, Choi, Jun-Pyo, Kim, Sae-Hoon, Chang, Yoon-Seok, Akdis, Mübeccel, Akdis, Cezmi A, van de Veen, Willem

“…Allergen-specific immunotherapy (AIT) is considered the only curative treatment for allergic diseases mediated by immunoglobulin E (IgE). Currently, the route…”
Get full text

Dupilumab treatment decreases MBC2s, correlating with reduced IgE levels in pediatric atopic dermatitis by Starrenburg, Margot E., Bel Imam, Manal, Lopez, Juan F., Buergi, Laura, Nguyen, N. Tan, Nouwen, Anouk E.M., Arends, Nicolette J.T., Caspers, Peter J., Akdis, Mübeccel, Pasmans, Suzanne G.M.A., van de Veen, Willem

“…A preference for type 2 immunity plays a central role in the pathogenesis of atopic dermatitis (AD). Dupilumab, an mAb targeting the IL-4 receptor α (IL-4Rα)…”
Get full text

The epithelial barrier: The gateway to allergic, autoimmune, and metabolic diseases and chronic neuropsychiatric conditions by Yazici, Duygu, Ogulur, Ismail, Pat, Yagiz, Babayev, Huseyn, Barletta, Elena, Ardicli, Sena, Bel imam, Manal, Huang, Mengting, Koch, Jana, Li, Manru, Maurer, Debbie, Radzikowska, Urszula, Satitsuksanoa, Pattraporn, Schneider, Stephan R., Sun, Na, Traidl, Stephan, Wallimann, Alexandra, Wawrocki, Sebastian, Zhakparov, Damir, Fehr, Danielle, Ziadlou, Reihane, Mitamura, Yasutaka, Brüggen, Marie-Charlotte, van de Veen, Willem, Sokolowska, Milena, Baerenfaller, Katja, Nadeau, Kari, Akdis, Mubeccel, Akdis, Cezmi A.

“…Since the 1960 s, our health has been compromised by exposure to over 350,000 newly introduced toxic substances, contributing to the current pandemic in…”
Get full text